Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Health & Life Co., Ltd. (1781:TWSE), powered by AI.
Health & Life Co., Ltd. is currently trading at $11.95. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Health & Life Co., Ltd. on Alpha Lenz.
View Health & Life Co., Ltd.'s valuation metrics on Alpha Lenz.
“Health & Life Co., Ltd.'s ROE is -17.3%. Explore profitability and growth together.”
Ask for details →Health & Life Co., Ltd. is a medical technology manufacturer specializing in health technology, with a primary focus on products for cardiovascular disease management, in-vitro diagnostics, and respiratory care. Established in 1996 and headquartered in Taipei, Taiwan, the company is recognized for its research-driven approach and commitment to quality and continuous product innovation. Health & Life Co., Ltd. develops and distributes a wide array of medical devices, including digital blood pressure monitors, blood glucose meters, nebulizers, and electronic thermometers, which are distributed globally under both its own and OEM brands. The firm's expertise encompasses engineering, manufacturing, and international regulatory compliance, with multiple patents for advancements in blood pressure measurement and diagnostic technologies. Health & Life Co., Ltd. plays a vital role in the medical equipment supply chain, supporting healthcare providers and patients worldwide by improving access to essential monitoring and diagnostic tools, and is regarded as an important contributor to advancements in non-invasive and preventive health management solutions.
“Health & Life Co., Ltd.'s ROE is -17.3%. Explore profitability and growth together.”
Ask for details →Health & Life Co., Ltd. (ticker: 1781) is a company listed on TWSE in the Healthcare sector (Medical Devices).
The current price is 11.95 with a P/E ratio of -x and P/B of -x.
ROE is -17.28% and operating margin is -15.93%. Annual revenue is $398M.